Showing results (41-50 of 120) with videos related to
Sort By:
Pageof 12
Hybridoma|January 1, 1985
Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitroD G Maloney, M S Kaminski, D Burowski, et al.Cytotherapy|June 19, 2004
The immune response to breast cancer, and the case for DC immunotherapyC P Allan, C J Turtle, P N Mainwaring, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1986
Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variantsM S Kaminski, K Kitamura, D G Maloney, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1991
Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expressionS R Riddell, M Rabin, A P Geballe, et al.Journal of Virology|August 10, 2000
Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genesL J Cooper, M Kalos, D A Lewinsohn, et al.Proceedings of the National Academy of Sciences of the United States of America|July 21, 1999
CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cellsD Bonnet, E H Warren, P D Greenberg, et al.Blood|August 8, 1998
Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant cloneT A Davis, D G Maloney, D K Czerwinski, et al.British Journal of Anaesthesia|January 1, 1996
Prilocaine 3% is superior to a mixture of bupivacaine and lignocaine for peribulbar anaesthesiaU R Döpfmer, D G Maloney, P A Gaynor, et al.Blood|April 1, 1994
Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxisC R Li, P D Greenberg, M J Gilbert, et al.Hematology. American Society of Hematology. Education Program|November 28, 2001
Non-myeloablative transplants for malignant diseaseR F Storb, R Champlin, S R Riddell, et al.Pageof 12